Skip to main content

Disruptive Innovation to Treat Alzheimer’s and Parkinson’s diseases: new target, new patented drug, new therapeutic strategy.

Project description

A chimeric peptide key to the treatment of Alzheimer's and Parkinson's diseases

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

AMYPORE
Address
Boulevard Elie Corradi 51
13240 Septemes-les-vallons
France
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000